181 related articles for article (PubMed ID: 15041044)
1. Antinucleosome antibodies in SLE: a two-year follow-up study of 101 patients.
Ghirardello A; Doria A; Zampieri S; Tarricone E; Tozzoli R; Villalta D; Bizzaro N; Piccoli A; Gambari PF
J Autoimmun; 2004 May; 22(3):235-40. PubMed ID: 15041044
[TBL] [Abstract][Full Text] [Related]
2. Antinucleosome antibodies and systemic lupus erythematosus.
Düzgün N; Sahin M; Genç Y; Tutkak H
Ann N Y Acad Sci; 2007 Aug; 1109():421-8. PubMed ID: 17785331
[TBL] [Abstract][Full Text] [Related]
3. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus.
Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC
Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702
[TBL] [Abstract][Full Text] [Related]
4. Nucleosomes are major T and B cell autoantigens in systemic lupus erythematosus.
Bruns A; Bläss S; Hausdorf G; Burmester GR; Hiepe F
Arthritis Rheum; 2000 Oct; 43(10):2307-15. PubMed ID: 11037891
[TBL] [Abstract][Full Text] [Related]
5. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases.
Půtová I; Dostal C; Becvar R
Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316
[TBL] [Abstract][Full Text] [Related]
6. Performance of anti-C1q, antinucleosome, and anti-dsDNA antibodies for detecting concurrent disease activity of systemic lupus erythematosus.
Mok CC; Ho LY; Leung HW; Wong LG
Transl Res; 2010 Dec; 156(6):320-5. PubMed ID: 21078493
[TBL] [Abstract][Full Text] [Related]
7. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
8. Antinucleosome antibodies correlate with the disease severity in children with systemic lupus erythematosus.
Wu JF; Yang YH; Wang LC; Lee JH; Shen EY; Chiang BL
J Autoimmun; 2006 Sep; 27(2):119-24. PubMed ID: 16919912
[TBL] [Abstract][Full Text] [Related]
9. The relevance of autoantigen source and cutoff definition in antichromatin (nucleosome) antibody immunoassays.
Villalta D; Tozzoli R; Bizzaro N; Tonutti E; Ghirardello A; Doria A
Ann N Y Acad Sci; 2005 Jun; 1050():176-84. PubMed ID: 16014532
[TBL] [Abstract][Full Text] [Related]
10. Detection of nucleosome particles in serum and plasma from patients with systemic lupus erythematosus using monoclonal antibody 4H7.
Williams RC; Malone CC; Meyers C; Decker P; Muller S
J Rheumatol; 2001 Jan; 28(1):81-94. PubMed ID: 11196548
[TBL] [Abstract][Full Text] [Related]
11. Antinuclear antibodies following infliximab treatment in patients with rheumatoid arthritis or spondylarthropathy.
De Rycke L; Kruithof E; Van Damme N; Hoffman IE; Van den Bossche N; Van den Bosch F; Veys EM; De Keyser F
Arthritis Rheum; 2003 Apr; 48(4):1015-23. PubMed ID: 12687543
[TBL] [Abstract][Full Text] [Related]
12. [Role of the nucleosome in the physiopathology of systemic lupus erythematosus].
Amoura Z; Piette JC
Ann Med Interne (Paris); 2003 Feb; 154(1):25-32. PubMed ID: 12746656
[TBL] [Abstract][Full Text] [Related]
13. Anti-dsDNA antibody assay: high specificity and sensitivity with a filtration radioassay in comparison to low specificity with the standard ELISA.
Yu L; Wang J; O'Dell JR; Oates J; Arend WP; Eisenbarth GS
J Rheumatol; 2007 Apr; 34(4):734-9. PubMed ID: 17407230
[TBL] [Abstract][Full Text] [Related]
14. Anti-nucleosome antibodies as a disease activity marker in patients with systemic lupus erythematosus.
Suleiman S; Kamaliah D; Nadeem A; Naing NN; Che Maraina CH
Int J Rheum Dis; 2009 Jul; 12(2):100-6. PubMed ID: 20374326
[TBL] [Abstract][Full Text] [Related]
15. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis.
Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P
Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973
[TBL] [Abstract][Full Text] [Related]
16. Antinucleosome antibody is a major autoantibody in localized scleroderma.
Sato S; Kodera M; Hasegawa M; Fujimoto M; Takehara K
Br J Dermatol; 2004 Dec; 151(6):1182-8. PubMed ID: 15606513
[TBL] [Abstract][Full Text] [Related]
17. Anti-nucleosome antibodies in patients with systemic lupus erythematosus of recent onset. Potential utility as a diagnostic tool and disease activity marker.
Simón JA; Cabiedes J; Ortiz E; Alcocer-Varela J; Sánchez-Guerrero J
Rheumatology (Oxford); 2004 Feb; 43(2):220-4. PubMed ID: 13130152
[TBL] [Abstract][Full Text] [Related]
18. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus.
Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M
Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456
[TBL] [Abstract][Full Text] [Related]
19. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis.
Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC
Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137
[TBL] [Abstract][Full Text] [Related]
20. B cell depletion therapy in systemic lupus erythematosus: effect on autoantibody and antimicrobial antibody profiles.
Cambridge G; Leandro MJ; Teodorescu M; Manson J; Rahman A; Isenberg DA; Edwards JC
Arthritis Rheum; 2006 Nov; 54(11):3612-22. PubMed ID: 17075806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
